Article
New Generic Products for 2015
Author(s):
Get ready to substitute these generics, if you aren't doing so already.
Get ready to substitute these generics, if you aren’t doing so already.
Guanfacine Extended-Release Tablets
Marketed by: Teva Pharmaceuticals
Compare to: Intuniv (Shire)
Indication: Guanfacine extended-release tablets are a nonstimulant medication indicated for the treatment of attention-deficit/hyperactivity disorder. The drug can be used as monotherapy or as an adjunctive therapy to stimulant medications.
Dosage Form: Tablets: 1, 2, 3, and 4 mg
Oxycodone Hydrochloride Tablets, USP (C-II)
Marketed by: Amneal Pharmaceuticals, LLC
Compare to: Roxicodone (Mallinckrodt Inc)
Indication: Oxycodone hydrochloride tablets (C-II) are indicated for the treatment of moderate to severe pain when the use of an opioid analgesic is appropriate.
Dosage Form: Tablets: 5, 10, 15, 20, or 30 mg
Enoxaparin Sodium Injection, USP
Marketed by: Teva Pharmaceutical Industries Ltd
Compare to: Lovenox (Sanofi)
Indication: Enoxaparin sodium injection is used for prophylaxis of deep vein thrombosis (DVT) in patients undergoing abdominal surgery or hip or knee replacement surgery, or medical patients with severely restricted mobility during acute illness; it is also used for the treatment of acute DVT.
Dosage Form: Injectable: 30 mg/0.3 mL, 40 mg/0.4 mL, 60 mg/0.6 mL, 80 mg/0.8 mL, 100 mg/1 mL, 120 mg/0.8 mL, and 150 mg/1 mL
Argatroban Injection in 0.9% Sodium Chloride
Marketed by: Teva Pharmaceuticals, Inc
Compare to: Argatroban Injection in 0.9% Sodium Chloride Dilution required (Sandoz, Inc)
Indication: Argatroban Injection is indicated for prophylaxis or treatment of thrombosis in adult patients with heparin- induced thrombocytopenia (HIT). It is also indicated as an anticoagulant in adult patients with or at risk for HIT undergoing percutaneous coronary intervention.
Dosage Form: Intravenous infusion: premixed formulation of 250 mg of argatroban in 250 mL of aqueous sodium chloride solution; dilution is not required
Buprenorphine Hydrochloride Sublingual Tablets
Marketed by: Mylan, Inc
Compare to: Subutex Sublingual Tablets (Reckitt Benckiser)
Indication: This generic version of Reckitt Benckiser’s Subutex Sublingual Tablets is indicated for the treatment of opioid dependence and is preferred for induction.
Dosage Form: Tablets: 2 and 8 mg
Marketed by: Teva Pharmaceutical Industries, Ltd
Compare to: Nafcillin for Injection, USP (Sandoz)
Indication: This medication is indicated for the treatment of infections caused by penicillinase-producing staphylococci that have demonstrated susceptibility to the drug. Culture and susceptibility tests should be performed initially to determine the causative organism and its susceptibility to the drug. It is available for intramuscular or intravenous use.
Dosage Form: Injectable: 1 and 2 g/ vial
Risedronate Sodium Tablets, USP
Marketed by: Teva Pharmaceuticals
Compare to: Actonel (Actavis Plc)
Indication: Risedronate sodium tablets are indicated to treat or prevent postmenopausal osteoporosis by helping to increase bone mass and reduce the odds of a spinal or nonspinal fracture. The product is also used to treat or prevent osteoporosis in men and women who are also taking corticosteroid medications and to treat Paget’s disease of the bone.
Dosage Form: Tablets: 5, 30, and 35 mg
Norethindrone and Ethinyl Estradiol Tablets (Chewable) and Ferrous Fumarate Tablets (Chewable)
Marketed by: Mylan
Compare to: Generess Fe tablets (Warner Chilcott)
Indication: Norethindrone and ethinyl estradiol tablets (chewable) and ferrous fumarate tablets (chewable) are both indicated for preventing pregnancy in women who decide to use oral contraceptives. The tablets must be taken exactly as directed. Cigarette smoking increases the risk of serious cardiovascular adverse effects from oral contraceptive use, and this risk increases with age.
Dosage Form: 28-tablet blister packs
Amlodipine and Valsartan Tablets
Marketed by: Teva Pharmaceutical Industries Ltd
Compare to: Exforge (Novartis Pharmaceuticals)
Indication: Amlodipine, a dihydropyridine calcium channel blocker, and valsartan, an angiotensin II—receptor blocker, are indicated for the treatment of hypertension. It may be used in patients (1) whose blood pressure is not adequately controlled on monotherapy or (2) who require multiple drugs to control blood pressure. The dose should be taken once a day without regard to food.
Dosage Form: Tablets: 5 mg/160 mg, 10 mg/160 mg, 5 mg/320 mg, 10 mg/320 mg
Marketed by: Mylan, Inc
Compare to: Epivir-HBV (GlaxoSmithKline)
Indication: These tablets are indicated for the treatment of chronic hepatitis B virus (HBV) infection associated with evidence of hepatitis B viral replication and active liver inflammation. Use of lamivudine has been associated with lactic acidosis and fatty liver disease. Acute exacerbations of HBV infection have occurred upon discontinuation. In patients with unrecognized or untreated HIV, resistance may emerge while treating HBV infection with lamivudine.
Dosage Form: Tablets: 100 mg
